Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Purple Biotech Plans To Change Ratio Of ADS To Ordinary Shares To ADS Ratio Of 1 ADS Representing 200 Ordinary Shares

Author: Benzinga Newsdesk | September 11, 2024 04:19pm

- SEC Filing

Posted In: PPBT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist